Good Morning!

🌡 TradingLab’s Headline Roundup

The robotics trade is starting to move. Surgical systems, warehouse automation, machine vision, and smart factories are turning “Physical AI” into real business. MarketBeat’s 7 Stocks to Buy Before the Robotics Revolution reveals 7 companies positioned before Wall Street piles in. Reveal The 7 Stocks.

Markets are closed today for Juneteenth. But what a week to recap.

Trump signed the US-Iran peace MOU at Versailles on Wednesday - the formal end of a 108-day war that sent oil to $126, crashed markets, and pushed inflation to a three-year high. Brent is now back below $75 and heading toward pre-conflict levels. Oil drove over 60% of the May CPI surge. If it stays here, the July inflation print changes dramatically.

Markets bounced back Friday after the initial Wednesday selloff - the Russell 2000 led with +2.12%, Nasdaq gained 1.91%, and the S&P recovered 1.08% - as the Iran signing and lower oil gave investors something to buy. The week ends with the peace deal signed, the Fed hawkish, oil at $75, and markets trying to figure out which one matters more.

🏛️ Stock Markets

  • Kalshi: Have a read on where BTC or ETH is heading? Trade it. Real crypto outcomes, peer-to-peer markets, no house edge. Start with a free $10 here. Claim $10 Free.

  • US-Iran MOU signed at Versailles - the war is officially over - Trump signed the 14-point Memorandum of Understanding at Versailles on Wednesday, providing for the immediate opening of the Strait of Hormuz, removal of the US naval blockade, and a framework for further negotiations over 60 days. 108 days of war. One signature. The most important macro event of 2026 is done.

  • Warsh abolishes forward guidance - 9 of 18 FOMC members now see a 2026 hike - Warsh held rates at 3.50-3.75% but eliminated forward guidance entirely, raised the PCE inflation forecast to 3.6% for year-end, and became the first Fed chair to refuse to submit his own dot plot projections - announcing five task forces to review Fed operations. The Fed just became genuinely unpredictable. That's a new risk for markets.

  • Markets bounced Friday - Russell 2000 +2.12%, Nasdaq +1.91%, S&P +1.08% - Equities rallied back Thursday as the Iran signing and lower oil prices gave investors a reason to buy after Wednesday's Fed-driven selloff, with the Russell 2000 leading on modest Treasury yield declines. The market absorbed a hawkish shock and bounced. That's a resilient tape.

  • Brent back below $75 - heading toward pre-conflict levels - Oil drove over 60% of May's CPI increase. With Brent at $75 and the Strait reopened, the path to a materially cooler July inflation print is real - and that changes Warsh's September dot plot calculus entirely.

  • SpaceX falls 5% after debut surge - Cursor deal the focus - SpaceX reversed gains to fall 5% Wednesday after the hawkish Fed decision, even as it confirmed the $60 billion acquisition of AI coding tool Cursor. Three days public, already doing one of the biggest M&A deals of the year.

  • Markets closed today - Juneteenth federal holiday - NYSE and Nasdaq both closed. Next major catalyst: June CPI, due mid-July. If oil stays at $75, that number could be the most important data release of the summer.

₿ Crypto

🔓 FREE PREVIEW: These alerts are delayed. Upgrade to access them in real-time and join my trading community.

$HIMS: Entered at $22.98. Up 55%. +$49,920 in the Bag.

On February 5th, I took a position in $HIMS at $22.98. I kept it low-key - volatile stock, needed room to breathe.

Yesterday I posted this to the community:

4,000 shares. $35.46 current price. +$49,920.

Why It Kept Running

This wasn't luck. The thesis kept getting confirmed. Hims & Hers posted Q1 2026 revenue of $608.1 million, with subscribers reaching nearly 2.6 million and full-year 2026 guidance raised to $2.8-$3.0 billion - driven by an accelerating domestic business and a strategic pivot into branded GLP-1 weight-loss products that's showing real early demand. The company completed its acquisition of Eucalyptus in June, expanding its international footprint, while Barclays raised their price target to $39 from $29 this week on strong GLP-1 growth. The obesity market tailwind is real and Hims is positioning directly into it.

The stock hasn't been a straight line - it plunged 13% on earnings day in May before recovering hard. That's exactly why I said at entry: expect it to move up/down big amounts. Holding through the noise is what turns a good idea into a great trade.

Still Holding

I haven't taken a single share off. The GLP-1 story is still early. The analyst upgrades are coming in. And a Needham price target of $35 - already hit - with Barclays now at $39 suggests there's more room left.

This one has more to give.

I posted this trade on February 5th at $22.98 - in the Discord, in real time, before it moved. Members who got in are sitting on 55% gains right now. The next setup is already being watched. The $50 weekly trial gets you full access to every trade the moment it drops - entries, updates, and live management. Start your 7-day trial here - cancel any time.

🚨 Want the NEXT trade, not the recap?

Inside TradingLab Premium you get:

⚡ Real-time entries
⚡ Live trade management
⚡ Profit-protection updates
⚡ Analyst breakdowns as the trade develops

If you’re serious about catching moves like this before they run, not after, you know where to be.

🌡 Free Trading Resources

Here's a list of free trading websites and resources that can really help your trading game:

If you have any websites that you feel should be added to this list, feel free to reply with suggestions. LET'S GET THIS LIST HUGE! 🔥

Stay ahead, stay informed, and most importantly, stay profitable.

‘til next time,

TradingLab

Keep Reading